Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
IEEE Transactions on Neural Networks and Learning Systems|March 3, 2025
When Heterophily Meets Heterogeneous Graphs: Latent Graphs Guided Unsupervised Representation LearningZhixiang Shen, Zhao Kang
Medicine|November 5, 2025
Association of systemic immune-inflammatory index with all-cause and cardiovascular mortality among individuals with diabetes: Evidence from the NHANES 2001 to 2018Mingfang Jiang, Quan Liu, Yamei Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 18, 2015
[A multicenter clinical trial of caffeic acid tablet in treatment of 103 primary immune thrombocytopenia patients]Ping Qin, Yu Wei, Ming Hou, et al.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion|December 13, 2017
[Strategy programming for acupuncture development along One-Belt-One-Road countries]Yuyang Yang, Zhixiang Shen, Zhongchao Wu, et al.
Annals of Hematology|September 7, 2014
Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patientsPengpeng Xu, Dong Yu, Li Wang, et al.
Experimental and Therapeutic Medicine|March 27, 2014
Endostar combined with radiotherapy increases radiation sensitivity by decreasing the expression of TGF-β1, HIF-1α and bFGFYaogui Wu, Yongfa Zheng, Zhixiang Shen, et al.
Annals of Hematology|August 3, 2014
The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in ChinaXiaoyang Li, Yunxiang Zhang, Weili Zhao, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 24, 2014
[Clinical features and prognostic analysis of 75 primary myelofibrosis patients]Qing Yu, Lan Xu, Xiaodong Gao, et al.
Clinical Therapeutics|August 22, 2009
Nilotinib for imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase, accelerated phase, or blast crisis: a single- and multiple-dose, open-label pharmacokinetic study in Chinese patientsLi Zhou, Fanyi Meng, Ophelia Yin, et al.
Cancer Communications (London, England)|May 31, 2018
Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trialYan Qin, Yuqin Song, Zhixiang Shen, et al.
Pageof 14